(Q34653094)

3 August 2017

title

The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 (English)

1 reference

3 August 2017

1 reference

1 reference

Ronald E Gangnon

2

0 references

Susan B Bressler

8

object named as

Susan B Bressler

1 reference

3 August 2017

Matthew D Davis

1

1 reference

3 August 2017

Li-Yin Lee

3

1 reference

3 August 2017

Larry D Hubbard

4

1 reference

3 August 2017

Barbara E K Klein

5

1 reference

3 August 2017

Ronald Klein

6

1 reference

3 August 2017

Frederick L Ferris

7

1 reference

3 August 2017

Roy C Milton

9

1 reference

3 August 2017

Age-Related Eye Disease Study Group

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

3 August 2017

number of pages

15

1 reference

inferred from page(s)

published in

JAMA Ophthalmology

1 reference

3 August 2017

volume

123

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

1484-1498

1 reference

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472813

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial

26 October 2018

1 reference

12 December 2020

Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group

1 reference

12 December 2020

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

12 December 2020

Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group

1 reference

12 December 2020

10.1001/ARCHOPHT.123.11.1484

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference